Tetrac

Modify Date: 2024-01-02 19:02:12

Tetrac structure	Common Name	Tetrac
	CAS Number	67-30-1	Molecular Weight	747.82900
	Density	2.727g/cm3	Boiling Point	544.8ºC at 760 mmHg
	Molecular Formula	C₁₄H₈I₄O₄	Melting Point	230 °C
	MSDS	Chinese USA	Flash Point	283.3ºC
	Symbol	GHS06	Signal Word	Danger

Use of Tetrac

Tetrac (Tetraiodothyroacetic acid), a deaminated analogue of L-thyroxine (T4), and is a thyrointegrin receptor antagonist. Tetrac blocks the actions of T3 and T4 as well as different growth factors-mediated angiogenesis. Tetra also has anticancer activity[1][2].

Name	2-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]acetic acid
Synonym	More Synonyms

Description	Tetrac (Tetraiodothyroacetic acid), a deaminated analogue of L-thyroxine (T4), and is a thyrointegrin receptor antagonist. Tetrac blocks the actions of T3 and T4 as well as different growth factors-mediated angiogenesis. Tetra also has anticancer activity[1][2].
Related Catalog	Research Areas >> Cancer
In Vitro	Tetrac (0.01-1 μM; 2-6 d) induces anti-proliferation in HT-29 and HCT116 cells with different K-RAS status[3]. Tetrac (0.1 μM; 30 min) inhibits activation of ERK1/2 in HT-29 and HCT116 cells[3]. Tetrac (0.1 μM; 24 h) inhibits expression of CCND1 and c-Myc, but promotes expression of CASP2 and THBS1[3]. Cell Proliferation Assay[3] Cell Line: HT-29 and HCT116 cells Concentration: 0.01, 0.1, 1 μM Incubation Time: 0, 2, 4, 6 days Result: Induced anti-proliferation of K-RAS wild-type colorectal cancer cells. Western Blot Analysis[3] Cell Line: HT-29 and HCT116 cells Concentration: 0.1 μM Incubation Time: 30 min Result: Inhibited constitutively activated ERK1/2, and this inhibition can remove by anti-integrin αvβ3 antibody pretreatment.
In Vivo	Tetrac (35 μg; p.o. for 40 days) inhibits tumor inoculation, growth and integrin expression in mice[4]. Animal Model: Wild-type male Balb/C mice aged 8 weeks are inoculated with 102B16F10 or B16LS9 cells[4] Dosage: 35 μg per day Administration: P.o. (added to the drinking water) daily for 40 days Result: Delayed the onset of ocular melanoma. Reduced the S-100 and integrin staining level in the B16F10 mice model.
References	[1]. Schmohl KA, et, al. Tetrac as an anti-angiogenic agent in cancer. Endocr Relat Cancer. 2019 Jun 1; 26(6):R287-R304. [2]. Davis PJ, et, al. Nongenomic Actions of Thyroid Hormone: the Integrin Component. Physiol Rev. 2020 Jun 25. [3]. Chin YT, et, al. Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status. Front Endocrinol (Lausanne). 2019 Mar 12; 10:130. [4]. Ashur-Fabian O, et, al. Tetrac Delayed the Onset of Ocular Melanoma in an Orthotopic Mouse Model. Front Endocrinol (Lausanne). 2019 Jan 8; 9:775. [5]. Rajabi M, et, al. Synthesis of new analogs of tetraiodothyroacetic acid (tetrac) as novel angiogenesis inhibitors for treatment of cancer. Bioorg Med Chem Lett. 2018 Apr 15;28(7):1223-1227.

Density	2.727g/cm3
Boiling Point	544.8ºC at 760 mmHg
Melting Point	230 °C
Molecular Formula	C₁₄H₈I₄O₄
Molecular Weight	747.82900
Flash Point	283.3ºC
Exact Mass	747.66000
PSA	66.76000
LogP	5.23000
Index of Refraction	1.801

Symbol	GHS06
Signal Word	Danger
Hazard Statements	H300
Precautionary Statements	P264-P301 + P310
Personal Protective Equipment	Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges
Hazard Codes	T+
Risk Phrases	28
Safety Phrases	45
RIDADR	UN 2811 6.1/PG 1
RTECS	CY1585800
Hazard Class	6.1
HS Code	2918990090

3,5-Diiodothyro...

CAS#:1155-40-4

~90%

Tetrac

CAS#:67-30-1

Literature: Bridoux, Alexandre; Khan, Riaz A.; Chen, Celei; Cheve, Gwenael; Cui, Huadong; Dyskin, Evgeny; Yasri, Aziz; Mousa, Shaker A. Journal of Enzyme Inhibition and Medicinal Chemistry, 2011 , vol. 26, # 6 p. 871 - 882

(4-hydroxy-3,5-...

CAS#:83799-60-4

Tetrac

CAS#:67-30-1

Literature: US2011/105482 A1, ;

[4-(4-methoxy-p...

CAS#:861065-72-7

Tetrac

CAS#:67-30-1

Literature: US2011/105482 A1, ;

Mequinol

CAS#:150-76-5

Tetrac

CAS#:67-30-1

Literature: US2011/105482 A1, ;

ethyl 3,5-diiod...

CAS#:85828-82-6

Tetrac

CAS#:67-30-1

Literature: Biochemical Journal, , vol. 63, p. 601,603

ethyl 2-(3,5-di...

CAS#:101588-11-8

Tetrac

CAS#:67-30-1

Literature: US2011/105482 A1, ;

1-(4-chlorometh...

CAS#:860687-73-6

Tetrac

CAS#:67-30-1

Literature: Biochemical Journal, , vol. 50, p. 438

[3,5-diiodo-4-(...

CAS#:855937-68-7

Tetrac

CAS#:67-30-1

Literature: Biochemical Journal, , vol. 50, p. 438

Precursor 8
CAS#:1155-40-4 3,5-Diiodothyro... CAS#:83799-60-4 (4-hydroxy-3,5-... CAS#:861065-72-7 [4-(4-methoxy-p... CAS#:150-76-5 Mequinol
CAS#:85828-82-6 ethyl 3,5-diiod... CAS#:101588-11-8 ethyl 2-(3,5-di... CAS#:860687-73-6 1-(4-chlorometh... CAS#:855937-68-7 [3,5-diiodo-4-(...
DownStream 0

HS Code	2918990090
Summary	2918990090. other carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

Tetraiodothyroacetic acid-tagged liposomes for enhanced delivery of anticancer drug to tumor tissue via integrin receptor

J. Control. Release 164(2) , 213-20, (2012)

Nanoparticles have demonstrated potential for promoting drug delivery to tumor sites and enhancing uptake. Here, we report tetraiodothyroacetic acid (tetrac) as a promising new targeting moiety for de...

Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma.

Thyroid 20(3) , 281-6, (2010)

Tetraiodothyroacetic acid (tetrac) is a deaminated analogue of L-thyroxine that blocks the actions of L-thyroxine and 3,5,3'-triiodo-L-thyronine at the cell surface receptor for thyroid hormone on int...

Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts.

Lung Cancer 76(1) , 39-45, (2012)

Thyroid hormone stimulates cell proliferation of several types of cancers and stimulates cancer-relevant angiogenesis. In the present study, we investigated the proliferative effect of thyroid hormone...

5-diiodophenoxy)-3

Thyroacetic acid,3,3',5,5'-tetraiodo

3,5-Diiodo-4-(4-hydroxy-3,5-diiodophenoxy)benzeneacetic acid

Tetrac

MFCD00055932

[4-(4-hydroxy-3

4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenylacetic acid

Benzeneacetic acid,3,5-diiodo-4-(4-hydroxy-3,5-diiodophenoxy)

3,3',5,5'-TETRAIODOTHYROACETIC ACID

Tetraiodothyroacetic acid

Acide 3,5,3',5'-tetraiodothyroacetique [French]

5-diiodophenyl] acetic acid

EINECS 200-649-1

Shanghai Jizhi Biochemical Technology Co., Ltd
China
Product Name: Tetrac
Price: ￥888.0/25mg ￥2288.0/100mg ￥8068.0/500mg
Purity: 98.0%
Stocking Period: Inquiry
Contact: Liu jia

DC Chemicals Limited
China
Product Name: Tetrac
Price: $Inquiry/250mg $Inquiry/100mg $Inquiry/1g
Purity: 98.0%
Stocking Period: 3 Day
Contact: Tony Cao

Dayang Chem (Hangzhou) Co., Ltd.
China
Product Name: 4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenylacetic acid
Price: $Inquiry/100g $Inquiry/1kg $Inquiry/100kg $Inquiry/1000kg
Purity: 98.0%
Stocking Period: Inquiry
Contact: Ms Wang

Get all suppliers and price by the below link:

Tetrac suppliers

Tetrac price

Dichloromethane
CAS#:75-09-2

Polyacrylic acid
CAS#:9003-01-4

sodium carbonate
CAS#:497-19-8

Silicon dioxide
CAS#:7631-86-9

Triethanolamine
CAS#:102-71-6

Demeton
CAS#:126-75-0

Water
CAS#:7732-18-5

4-(4-Piperidinyl)morpholine dihydrochloride
CAS#:53617-35-9

Diclofenac sodium
CAS#:15307-79-6

Budesonide
CAS#:51372-29-3

Tetrac

Use of Tetrac

Names

Tetrac Biological Activity

Chemical & Physical Properties

Safety Information

Synthetic Route

Precursor & DownStream

Customs

Articles28

Synonyms